Bio-Rad Laboratories (NYSE:BIO.B) Reaches New 12-Month Low – Here’s What Happened

Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO.B) reached a new 52-week low during trading on Monday . The stock traded as low as $223.15 and last traded at $223.15, with a volume of 26 shares trading hands. The stock had previously closed at $250.08.

Bio-Rad Laboratories Trading Down 10.8%

The firm has a market capitalization of $6.25 billion, a price-to-earnings ratio of -3.43 and a beta of 0.82. The firm’s 50 day moving average is $240.44 and its 200 day moving average is $287.07. The company has a quick ratio of 4.85, a current ratio of 6.48 and a debt-to-equity ratio of 0.18.

Bio-Rad Laboratories (NYSE:BIO.B) last released its earnings results on Thursday, May 1st. The company reported $2.54 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a negative net margin of 71.86% and a positive return on equity of 3.90%. The company had revenue of $585.40 million during the quarter.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.